Repligen

Activities: Distribution Manufacturing Pharmaceutical

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Naobios successfully optimises Sumagen's HIV vaccine for industrial production Naobios will now focus on developing processes for the cGMP manufacture of Sumagen's HIV-1 vaccine candidate
  3. Enzene launches EnzeneX 2.0 technology for biologics at CPHI Milan 2024 New platform enables uninterrupted processing and significant cost reductions
  4. New Berry bottle complements preservative-free eye treatment dispensing Easy-squeeze ophthalmic bottle designed for use with Aptar Pharma’s dispenser
  5. Domino makes it easier than ever for pharmaceutical manufacturers to explore individual dose serialisation New enhancements to the K600G printing solution streamline integration and usability

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Ecolab Life Sciences and Repligen launch novel chromatography resin for large-scale biologic manufacturing

Purolite's DurA Cycle is a protein A chromatography resin that can optimise large-scale purification processes
Regulatory

Purolite and Repligen launch a novel CH1 affinity resin for the purification of specialised mAbs

They launch Praesto CH1 a novel 70μm agarose-based affinite resin designed to purified specialised mAbs such as bispecifics or recombinant antibody fragments
Manufacturing

Sartorius and Repligen combine technologies for integrated bioreactor system

The two companies have incorporated Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor to simplify upstream process intensification
Manufacturing

Repligen partners with Daylight on mid-infrared tech

Through this agreement, Repligen will assume responsibility for the commercialisation of DRS Daylight’s Culpeo product
Manufacturing

Repligen plans Polymem acquisition to expand hollow fibre capabilities

The CDMO has made the acquisition to significantly expands hollow fibre membrane and module production capabilities for both industrial and bioprocessing markets
Manufacturing

Sartorius and Repligen collaborate on perfusion-enabled bioreactors

Joint technology to control cell growth, fluid management and cell retention would simplify development and cGMP manufacture of biological drugs
Manufacturing

Repligen completes expansion of US manufacturing facility in Massachusetts

More than doubles capacity for OPUS pre-packed chromatography columns
Subscribe now